We are thrilled to announce the latest addition to the International Council for Commonality in Blood Banking Automation's (ICCBBA) esteemed Board of Directors: Dr. Jelena Holovati.
With an extensive background in laboratory medicine, stem cell manufacturing, and accreditation, Dr. Holovati brings a wealth of knowledge and experience to our organization.
A Leader in Laboratory Medicine and Stem Cell Manufacturing
Dr. Holovati currently serves as a Professor in the Department of Laboratory Medicine and Pathology at the University of Alberta, Canada. In addition to her academic role, she holds the position of Laboratory Director for the Stem Cell Manufacturing Program at the Canadian Blood Services, overseeing operations in both Ottawa and Edmonton stem cell manufacturing centers. Her leadership extends further as she serves as a director of the Graduate Program at the University of Alberta and acts as a scientific consultant with the Alberta Health Services Tissue Transplant Program.
With a career spanning over two decades, Dr. Holovati has continually demonstrated her commitment to excellence in biomanufacturing, cell therapy, and medical laboratory initiatives. Her dedication to these fields is evident through her involvement in various national and international committees, including the American Association of Blood Banks Cell Therapy Standards Committee, Health Canada Lymphohematopoietic Cells Standards Committee, International Society for Cell Therapy Lab Practice Committee, and the Canadian Society for Transfusion Medicine Education Committee.
A History of Collaboration with ICCBBA
Dr. Holovati's journey with ICCBBA began in 2016, initially as a member and later taking on roles of increasing responsibility within the organization. She served as the chair of the (NATTAG) and contributed her expertise to the ICCBBA Standards Committee. Her active involvement and leadership within ICCBBA highlight her dedication to advancing ISBT 128 standards and best practices in blood banking automation.
In addition to her impressive professional accomplishments, Dr. Holovati is deeply committed to education, accreditation, policy development, and governance within her field. Her multidimensional approach to improving standards and practices ensures the delivery of safe and effective medical services to patients worldwide.
Looking Ahead
As ICCBBA welcomes Dr. Jelena Holovati to the Board of Directors, we anticipate her invaluable contributions to our mission of global adoption of the ISBT 128 standards. Her expertise and leadership will undoubtedly propel our organization forward as we continue to advance innovation and excellence in the field of blood banking automation and beyond.
Please join us in extending a warm welcome to Dr. Holovati as she embarks on this new role with ICCBBA. We look forward to working closely with her to drive positive change and enhance patient care on a global scale.
Stay connected, stay informed, and stay inspired with ICCBBA.
Subscribe to our newsletter at: https://www.isbt128.org/newsletter
About ICCBBA:
ICCBBA is the international standards organization responsible for the management and development of the ISBT 128 Standard.
The acronym ISBT was originally derived from the important role played by the International Society of Blood Transfusion in the development of the standard. Today it expands as Information Standard for Blood and Transplant. The number 128 reflects the 128 characters of the ISO/IEC 646 7-bit character set.
The acronym ICCBBA is derived from the International Council for Commonality in Blood Banking Automation.
For More Information
About ICCBBA:
Press Contact: Christina Salinas, Global Development Manager
Email: support@isbt128.org
Author
Christina Salinas
Global Development Manager